Core Laboratories Nv Stock Alpha and Beta Analysis
| CLB Stock | USD 19.69 0.58 3.04% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Core Laboratories NV. It also helps investors analyze the systematic and unsystematic risks associated with investing in Core Laboratories over a specified time horizon. Remember, high Core Laboratories' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Core Laboratories' market risk premium analysis include:
Beta 0.41 | Alpha 0.0827 | Risk 3.07 | Sharpe Ratio 0.0441 | Expected Return 0.14 |
Core Laboratories Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Core |
Core Laboratories Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Core Laboratories market risk premium is the additional return an investor will receive from holding Core Laboratories long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Core Laboratories. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Core Laboratories' performance over market.| α | 0.08 | β | 0.41 |
Core Laboratories expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Core Laboratories' Buy-and-hold return. Our buy-and-hold chart shows how Core Laboratories performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Core Laboratories Market Price Analysis
Market price analysis indicators help investors to evaluate how Core Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Core Laboratories shares will generate the highest return on investment. By understating and applying Core Laboratories stock market price indicators, traders can identify Core Laboratories position entry and exit signals to maximize returns.
Core Laboratories Return and Market Media
The median price of Core Laboratories for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 is 19.31 with a coefficient of variation of 6.51. The daily time series for the period is distributed with a sample standard deviation of 1.25, arithmetic mean of 19.18, and mean deviation of 1.0. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Core Laboratories declares 0.01 dividend | 10/24/2024 |
2 | Core Laboratories N.V. Q3 2024 Earnings Call Transcript | 10/25/2024 |
3 | Is the Options Market Predicting a Spike in CORE LABS INC Stock | 11/07/2024 |
4 | Is Core Laboratories Using Too Much Debt | 11/12/2024 |
| Core Laboratories dividend paid on 25th of November 2024 | 11/25/2024 |
5 | Disposition of 227 shares by Sow Teo of Core Laboratories at 20.42 subject to Rule 16b-3 | 11/29/2024 |
6 | Zacks Research Has Pessimistic Outlook of CLB Q4 Earnings - MarketBeat | 12/06/2024 |
7 | Is Now the Right Time to Buy Core Laboratories After Its 12 percent YTD Rise | 12/13/2024 |
8 | Disposition of 9604 shares by Mark Tattoli of Core Laboratories subject to Rule 16b-3 | 12/31/2024 |
9 | CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL | 01/03/2025 |
10 | Heres Why Hold Strategy is Apt for Core Laboratories Stock Now | 01/15/2025 |
About Core Laboratories Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Core or other stocks. Alpha measures the amount that position in Core Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.001973 | 0.002266 | 0.002039 | 0.001937 | Price To Sales Ratio | 1.92 | 1.62 | 1.46 | 2.7 |
Core Laboratories Upcoming Company Events
As portrayed in its financial statements, the presentation of Core Laboratories' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Core Laboratories' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Core Laboratories. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 31st of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Core Laboratories
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Core Laboratories Backtesting, Core Laboratories Valuation, Core Laboratories Correlation, Core Laboratories Hype Analysis, Core Laboratories Volatility, Core Laboratories History and analyze Core Laboratories Performance. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Core Laboratories technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.